Harmony Biosciences Holdings HRMY
$ 33.14
0.18%
Quarterly report 2024-Q3
added 10-29-2024
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. John Charles Jacobs M.B.A. |
Employees in the company |
150 |
Shares |
59.5 M |
Market Cap[1] |
$ 1.97 B |
EBITDA (LTM) |
$ 218 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.